Literature DB >> 7870993

Seizure threshold to lidocaine is decreased following repeated ECS (electroconvulsive shock).

J Kragh1, J Seidelin, T G Bolwig.   

Abstract

Seizure susceptibility to lidocaine was investigated in rats which had received repeated ECS (electroconvulsive shock). In the first experiment three groups of rats received an ECS daily for 18 days, an ECS weekly for 18 weeks, and 18 sham treatments, respectively. Twelve weeks after the last ECS all rats received a lidocaine challenge (LC) in the form of an intraperitoneal (IP) injection of lidocaine (65 mg/kg). After the injection the animals were observed for occurrence of motor seizures. A total of 67% (10/15), 47% (7/15), and 0% (0/18) of the daily, weekly, and sham groups, respectively, had motor seizures in response to the LC. In the second experiment five groups of rats received an ECS daily for 0, 1, 6, 18, and 36 days, respectively. Eighteen weeks after the last ECS all rats received an LC and 0% (0/15), 13% (2/15), 20% (3/15), 53% (8/15), and 58% (7/12), respectively, developed seizures in response to the LC. In the third experiment two groups of rats received daily ECS and sham-ECS, respectively. Twenty-four hours after the last ECS all rats received an LC. A total of 60% (9/15) of the ECS group and 0% (0/10) of the sham-ECS group had seizures in response to the LC.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7870993     DOI: 10.1007/bf02253542

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  Increased GABAB receptor function in mouse frontal cortex after repeated administration of antidepressant drugs or electroconvulsive shocks.

Authors:  J A Gray; A R Green
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

2.  Anticonvulsive and convulsive effects of lidocaine: comparison with those of phenytoin, and implications for mechanism of action concepts.

Authors:  W E Stone; M J Javid
Journal:  Neurol Res       Date:  1988-09       Impact factor: 2.448

3.  Behavioral analysis of the effect of substance P injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat.

Authors:  A E Kelley; M Cador; L Stinus
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Properties of maximal seizures, and their alteration by anticonvulant drugs and other agents.

Authors:  J E P TOMAN; E A SWINYARD; L S GOODMAN
Journal:  J Neurophysiol       Date:  1946-05       Impact factor: 2.714

5.  The importance of the convulsion in occurrence and rate of development of electroconvulsive threshold elevation.

Authors:  C F Essig; H G Flanary
Journal:  Exp Neurol       Date:  1966-04       Impact factor: 5.330

6.  Purinergic modulation of the seizure threshold for pentylenetetrazol in the rat.

Authors:  T F Murray; D Sylvester; C S Schultz; P Szot
Journal:  Neuropharmacology       Date:  1985-08       Impact factor: 5.250

Review 7.  Chronic electroconvulsive shock and neurotransmitter receptors--an update.

Authors:  C H Gleiter; D J Nutt
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

8.  The effect of repeated electroconvulsive shock on GABA synthesis and release in regions of rat brain.

Authors:  A R Green; N D Vincent
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

9.  Increased susceptibility to the epileptic effects of alcohol withdrawal following periodic electroconvulsive shocks.

Authors:  J P Pinel; P H Van Oot
Journal:  Biol Psychiatry       Date:  1978-06       Impact factor: 13.382

10.  Optimizing the pentetrazol infusion test for seizure threshold measurement.

Authors:  D J Nutt; S C Taylor; H J Little
Journal:  J Pharm Pharmacol       Date:  1986-09       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.